Montana Bids > Bid Detail

Constitutive Knockout Recovery Model Mice for Lyme Disease Studies

Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Level of Government: Federal
Category:
  • 88 - Live Animals
Opps ID: NBD00159810145753722
Posted Date: Sep 13, 2023
Due Date: Sep 18, 2023
Solicitation No: NOI-NIAID-23-2184302
Source: https://sam.gov/opp/16ba6b8920...
Follow
Constitutive Knockout Recovery Model Mice for Lyme Disease Studies
Active
Contract Opportunity
Notice ID
NOI-NIAID-23-2184302
Related Notice
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH NIAID
Looking for contract opportunity help?

Procurement Technical Assistance Centers (PTACs) are an official government contracting resource for small businesses. Find your local PTAC (opens in new window) for free government expertise related to contract opportunities.

General Information
  • Contract Opportunity Type: Presolicitation (Original)
  • All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
  • Original Published Date: Sep 13, 2023 12:13 pm EDT
  • Original Response Date: Sep 18, 2023 05:00 pm EDT
  • Inactive Policy: 15 days after response date
  • Original Inactive Date: Oct 03, 2023
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: 8820 - LIVE ANIMALS, NOT RAISED FOR FOOD
  • NAICS Code:
  • Place of Performance:
    Hamilton , MT 59840
    USA
Description

PRE-SOLICITATION NOTICE ** NOTICE OF INTENT



NOI-NIAID-23-2184302



NAICS – 112990



This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Taconic Biosciences Inc to procure Constitutive Knockout Recovery Model Mice to be used in studies characterizing the differential role of main skin-derived proteases in keratinocyte wound healing process and the modulatory effects of a new peptidase inhibitor isolated from Ixodes scapularis salivary glands, the vector of Lyme disease.



The NIH Rocky Mountain Laboratory (RML) Laboratory of Bacteriology (LB) Tick-Pathogen Transmission Unit (TPTU) focuses on understanding how molecules from ticks are critical for the success of tick feeding and pathogen transmission. A deeper understanding of tick feeding biology is needed to discover weak links that can be targeted for effective development of anti-tick and/or pathogen-blocking vaccines. Ticks are blood-sucking arthropods that developed through the evolution interesting strategies to modulate local skin defensive responses, such as itching, healing, hemostasis and inflammation. Skin-derived proteases are involved in signaling process of cell proliferation, migration, adhesion, matrix degradation, inflammatory cell chemotaxis and cytokine activation. Thus, they may be targets for saliva-derived molecules that are injected into the host during blood feeding and are also potentially involved facilitating pathogen transmission. TPTU is focusing studies in characterizing the differential role of main skin-derived proteases in keratinocyte wound healing process and the modulatory effects of a new peptidase inhibitor isolated from Ixodes scapularis salivary glands, the vector of Lyme disease. Since these skin-derived proteases seems to have an essential role in orchestrate the signaling involved in wound healing, and are good targets for vector arthropod molecules to avoid host skin barriers, the lab requires the use of Knock Out (KO) animals to evaluate the importance of signaling performed by these peptidases in the wound healing process in vivo. Findings from these studies will impact the understanding about vector biology with the goal of developing new strategies to control and treat vector-borne diseases. Taconic Biosciences Inc is the sole provider/breeder of the Constitutive Knockout Recovery Model Mice required for this study. The standard order will include a minimum of four (4) mutant mice (males and/or females), heterozygous for the selected mutation on a mixed 129S5;B6 background, validated genotyping protocols, and animal health data. Taconic Biosciences and NIH have worked exhaustively to reach an agreed upon license agreement containing the legal verbiage necessary to accommodate a license model for NIH to breed in house with each model with a fully executed license.



The statutory authority for this sole source requirement is 41 U.S.C. 253 (c) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-23-2184302) to Dana Monroe at dana.monroe@nih.gov by 5:00pm ET Monday, September 18, 2023. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.


Attachments/Links
Contact Information
Contracting Office Address
  • 5601 FISHERS LANE, SUITE 3D11
  • BETHESDA , MD 20892
  • USA
Primary Point of Contact
Secondary Point of Contact


History
  • Sep 13, 2023 12:13 pm EDTPresolicitation (Original)

TRY FOR FREE

Not a USAOPPS Member Yet?

Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.

Start Free Trial Today >